Abstract
Companies move towards niche products to boost productivity.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact
Pharmaceutical Research Open Access 06 June 2017
-
Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group
BMC Neurology Open Access 15 October 2015
-
Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal
Australia and New Zealand Health Policy Open Access 01 June 2007
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Owens, J. 2006 drug approvals: finding the niche. Nat Rev Drug Discov 6, 99–101 (2007). https://doi.org/10.1038/nrd2247
Issue Date:
DOI: https://doi.org/10.1038/nrd2247
This article is cited by
-
Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact
Pharmaceutical Research (2017)
-
Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group
BMC Neurology (2015)
-
Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006: An Analysis of FDA Adverse Event Reporting System Data
Drug Safety (2013)
-
Unraveling the autoimmune translational research process layer by layer
Nature Medicine (2012)
-
Off-Label-Therapie: aktuelle Probleme aus Sicht der Arzneimittelkommission der deutschen Ärzteschaft
Zeitschrift für Rheumatologie (2012)